Next-Generation Virtual Experience
In response to the recent COVID-19 pandemic, the urgency for rapid development, authorization/approval & supply continuity of a new mRNA platform vaccine required an adjustment of conventional development & regulatory approaches. The pharmaceutical industry & regulatory authorities globally, engaged in close & frequent interactions to ensure that a safe & effective vaccine could be globally distributed reliably & administered widely.
This Expert Xchange will feature interactive sessions with our speakers and panelists discussing the COVID Virus itself and the mutations that have developed, as well as development of the COVID-19 mRNA Vaccine and Regulatory Approval
The delivery of COVID-19 vaccines would not have been effectively achieved without several paradigm shifts:
Don’t miss out on this next-generation virtual experience – ISPE Expert Xchange!